title: Subtenon triamcinolone injection for postoperative cystoid macular edema associated with tafluprost.
abstract: OBJECTIVE
  We report the successful treatment of a case of cystoid macular edema (CME) associated with topical tafluprost, which was accompanied by serous retinal detachment (SRD).
  
  
  METHODS
  A 78-year-old woman underwent intraocular lens suture surgery, including anterior vitreous cutting, for crystalline lens dislocation in the right eye. Tafluprost was initiated 12 weeks after surgery. Intraocular pressure (IOP) was controlled at 10-14 mmHg. Visual acuity remained at 20/40-30/40. However, the patient complained of blurred vision (20/200) 9 months after surgery. CME accompanied by SRD was identified by optical coherence tomography (OCT) and treated with subtenon triamcinolone injection. Visual acuity rapidly increased to 20/50, and the volume of SRD decreased in a few days. Discontinuation of tafluprost and initiation of diclofenac eye drops improved visual acuity to 20/40 and resulted in improved OCT findings within a few weeks. Three months after injection, tafluprost was resumed along with diclofenac. No recurrence of CME occurred over the following 3 months, and IOP was controlled at 10-15 mmHg.
  
  
  CONCLUSIONS
  SRD is considered to be a symptom of treatment-resistant CME, which may lead to poor visual acuity after recovery. In such cases, subtenon triamcinolone injection should be strongly considered at an early stage.
authors.affiliation: Nojima Hospital, Tottori, Japan.
authors.forename: Kazuki
authors.initials: K
authors.lastname: Matsuura
authors.forename: Ryu
authors.initials: R
authors.lastname: Uotani
authors.forename: Yuki
authors.initials: Y
authors.lastname: Terasaka
keywords: cystoid macular edema; serous retinal detachment; subtenon triamcinolone; tafluprost
references.citation: Am J Ophthalmol. 2010 Feb;149(2):291-301.e5
references.pmid: 20103055
references.citation: J Cataract Refract Surg. 2001 Sep;27(9):1397-401
references.pmid: 11566522
references.citation: Arch Ophthalmol. 2005 Feb;123(2):186-92
references.pmid: 15710814
references.citation: Ophthalmology. 1999 May;106(5):1024-9
references.pmid: 10328408
references.citation: Am J Ophthalmol. 2002 Mar;133(3):403-5
references.pmid: 11860980
references.citation: Eur J Ophthalmol. 2005 Jan-Feb;15(1):158-61
references.pmid: 15751259
references.citation: Am J Ophthalmol. 2004 May;137(5):966-8
references.pmid: 15126179
references.citation: J Cataract Refract Surg. 2002 Oct;28(10):1814-8
references.pmid: 12388034
references.citation: Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4117-24
references.pmid: 20357196
references.citation: Clin Ophthalmol. 2012;6:2105-8
references.pmid: 23269859
references.citation: Am J Ophthalmol. 1998 Jul;126(1):134-5
references.pmid: 9683162
references.citation: Arch Ophthalmol. 2001 Mar;119(3):387-94
references.pmid: 11231772
references.citation: Clin Ophthalmol. 2013;7:7-14
references.pmid: 23293509
references.citation: J Ophthalmol. 2010;2010:690707
references.pmid: 21076526
references.citation: Jpn J Ophthalmol. 2002 Nov-Dec;46(6):656-9
references.pmid: 12543193
references.citation: J Ocul Pharmacol Ther. 2007 Dec;23(6):567-70
references.pmid: 18001244
references.citation: J Glaucoma. 2013 Oct-Nov;22(8):626-31
references.pmid: 22936280
references.citation: J Glaucoma. 2001 Jun;10(3):233-6
references.pmid: 11442189
references.citation: Acta Ophthalmol Suppl (Oxf ). 2008;242:7-13
references.pmid: 18752509
references.citation: PLoS One. 2012;7(3):e33913
references.pmid: 22442734
references.citation: Eur J Ophthalmol. 2003 Mar;13(2):221-2
references.pmid: 12696646
references.citation: Jpn J Ophthalmol. 2003 Jan-Feb;47(1):110-2
references.pmid: 12586189
references.citation: Am J Ophthalmol. 1998 Oct;126(4):602-4
references.pmid: 9780112